DE60124170D1 - Verwendung von Ascorbinsäurederivaten, um die Synthese von epidermalen Ceramiden zu erhöhen - Google Patents

Verwendung von Ascorbinsäurederivaten, um die Synthese von epidermalen Ceramiden zu erhöhen

Info

Publication number
DE60124170D1
DE60124170D1 DE60124170T DE60124170T DE60124170D1 DE 60124170 D1 DE60124170 D1 DE 60124170D1 DE 60124170 T DE60124170 T DE 60124170T DE 60124170 T DE60124170 T DE 60124170T DE 60124170 D1 DE60124170 D1 DE 60124170D1
Authority
DE
Germany
Prior art keywords
ascorbic acid
radical
iso
formula
preferred
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60124170T
Other languages
English (en)
Other versions
DE60124170T2 (de
Inventor
Isabelle Castiel
Corinne Ferraris
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Application granted granted Critical
Publication of DE60124170D1 publication Critical patent/DE60124170D1/de
Publication of DE60124170T2 publication Critical patent/DE60124170T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/676Ascorbic acid, i.e. vitamin C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE60124170T 2000-04-10 2001-03-27 Verwendung von Ascorbinsäurederivaten, um die Synthese von epidermalen Ceramiden zu erhöhen Expired - Fee Related DE60124170T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0004574 2000-04-10
FR0004574A FR2807320B1 (fr) 2000-04-10 2000-04-10 Utilisation de derives d'acide ascorbique pour augmenter la synthese des creramides epidermiques

Publications (2)

Publication Number Publication Date
DE60124170D1 true DE60124170D1 (de) 2006-12-14
DE60124170T2 DE60124170T2 (de) 2007-08-30

Family

ID=8849079

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60124170T Expired - Fee Related DE60124170T2 (de) 2000-04-10 2001-03-27 Verwendung von Ascorbinsäurederivaten, um die Synthese von epidermalen Ceramiden zu erhöhen

Country Status (7)

Country Link
US (2) US20020042380A1 (de)
EP (1) EP1145710B1 (de)
JP (2) JP2001316261A (de)
AT (1) ATE344016T1 (de)
DE (1) DE60124170T2 (de)
ES (1) ES2273789T3 (de)
FR (1) FR2807320B1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8039026B1 (en) 1997-07-28 2011-10-18 Johnson & Johnson Consumer Companies, Inc Methods for treating skin pigmentation
US20020006418A1 (en) * 1998-10-13 2002-01-17 John Kung Composition to enhance permeation of topical skin agents
US20020197244A1 (en) * 1998-12-07 2002-12-26 Miri Seiberg Compositions and methods for regulating phagocytosis and ICAM-1 expression
EP1192938A3 (de) * 2000-09-29 2004-01-02 JOHNSON & JOHNSON CONSUMER COMPANIES, INC. Zusammensetzung zur Verbesserung der Permeation von topischen Hautpflegemitteln
FR2825922B1 (fr) * 2001-06-15 2005-01-21 Oreal 2-hexadecanoate d'ascorbyle comme inhibiteur de no-synthase et utilisations
DE60302389T2 (de) * 2002-06-20 2006-07-13 L'oreal S.A. Kosmetische und/oder dermatologische Verwendung einer Zusammensetzung, die mindestens einen oxidationsempfindlichen hydrophilen Wirkstoff enthält, der mit mindestens einem Copolymer von Maleinsäureanhydrid stabilisiert ist
JP4129574B2 (ja) * 2002-08-06 2008-08-06 大塚製薬株式会社 老化防止剤
US20040161391A1 (en) * 2002-12-18 2004-08-19 L'oreal Ascorbic acid compounds as bleaching agents
FR2848846B1 (fr) * 2002-12-18 2005-01-28 Oreal Utilisation cosmetique de derives de l'acide ascorbique comme agents blanchissants
US7169382B2 (en) 2003-01-30 2007-01-30 L'oreal Reconstructed epidermis/skin equivalent comprising a ceramide 7 and /or 5.5 and lipid lamellar vesicular compositions comprising ceramide 7 and/or 5.5 compounds
FR2850666B1 (fr) * 2003-01-30 2007-09-07 Oreal Procedes de preparation d'un epiderme reconstruit supplemente en ceramide 7 et/ou 5.5.
FR2850579B1 (fr) * 2003-02-03 2006-08-18 Oreal Utilisation de mono-ou di-esters d'acide cinnamique ou de l'un de ses derives et de vitamine c, comme donneur de no
CA2456031A1 (fr) * 2003-02-03 2004-08-03 L'oreal Utilisation de mono- ou di-esters d'acide cinnamique ou de l'un de ses derives et de vitamine c, comme donneur de no
US20040175347A1 (en) * 2003-03-04 2004-09-09 The Procter & Gamble Company Regulation of mammalian keratinous tissue using hexamidine compositions
EP1620419A4 (de) * 2003-04-21 2008-07-23 Tagra Biotechnologies Ltd Stabilisierte ascorbinsäurederivative
FR2855047B1 (fr) * 2003-05-19 2007-11-30 Oreal Composition comprenant une base sphingoide, un activateur de la voie des 4-et/ou des 6-hydroxylases et un acide gras, utilisation pour renforcer la fonction barriere de la peau
EP1527777A1 (de) * 2003-10-31 2005-05-04 MERCK PATENT GmbH Zubereitung mit antioxidanten Eigenschaften, die einen Benzoesäureester der Ascorbinsäure enthält
JP4925579B2 (ja) * 2004-12-28 2012-04-25 大塚製薬株式会社 水中油型エマルジョンからなる固形組成物
US20070274932A1 (en) * 2006-05-15 2007-11-29 The Procter & Gamble Company Water in oil emulsion compositions containing sunscreen actives and siloxane elastomers
WO2007133768A2 (en) * 2006-05-15 2007-11-22 The Procter & Gamble Company Method of enhancing penetration of water-soluble actives
US20090011035A1 (en) * 2007-07-03 2009-01-08 Joseph Michael Zukowski Personal care composition
JP5165299B2 (ja) * 2007-07-20 2013-03-21 ポーラ化成工業株式会社 皮膚外用剤
FR2940612B1 (fr) 2008-12-30 2011-05-06 Oreal Association de monosaccharides avec l'acide ascorbique et son utilisation en cosmetique
FR2946252B1 (fr) 2009-06-08 2011-07-29 Fabre Pierre Dermo Cosmetique Bis esters d'acide gras insature sur l'acide ascorbique et leurs utilisations cosmetiques
FR2978963A1 (fr) 2011-08-11 2013-02-15 Ascorbix Nouveaux derives des furanones et composition pharmaceutique les contenant
US10071042B2 (en) * 2014-04-14 2018-09-11 Hayashibara Co., Ltd. External dermatological agent for anti-ageing

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3954809A (en) * 1973-01-22 1976-05-04 Kansas State University Research Foundation Preparation of l-ascorbate 2-sulfate from l-ascorbic acid
JPS60130582A (ja) * 1983-12-19 1985-07-12 Takeda Chem Ind Ltd 食品用酸化防止剤,アスコルビン酸誘導体およびその製造法
JPS6185308A (ja) * 1984-10-01 1986-04-30 Kanebo Ltd 皮膚化粧料
DE69019779T2 (de) * 1989-05-19 1995-12-14 Hayashibara Biochem Lab Alpha-Glycosyl-L-ascorbinsäure und ihre Herstellung und Verwendungen.
JP2832848B2 (ja) * 1989-10-21 1998-12-09 株式会社林原生物化学研究所 結晶2―O―α―D―グルコピラノシル―L―アスコルビン酸とその製造方法並びに用途
TW197375B (de) * 1990-11-19 1993-01-01 Hayashibara Biochem Lab
JPH07206840A (ja) * 1994-01-14 1995-08-08 Kanto Denka Kogyo Co Ltd アスコルビン酸−ヒドロキシカルボン酸結合体ならびにその製造方法
FR2715156B1 (fr) * 1994-01-20 1996-03-01 Oreal Mono-esters d'acide cinnamique ou de ses dérivés et de vitamine C, leur procédé de préparation et leur utilisation comme anti-oxydants dans des compositions cosmétiques, pharmaceutiques ou alimentaires.
FR2715565B1 (fr) * 1994-01-31 1996-03-15 Oreal Composition cosmétique ou dermatologique stabilisée contenant plusieurs précurseurs d'un même actif pour maximaliser sa libération, son utilisation.
US5470874A (en) * 1994-10-14 1995-11-28 Lerner; Sheldon Ascorbic acid and proanthocyanidine composition for topical application to human skin
FR2733148B1 (fr) * 1995-04-20 1997-05-30 Oreal Composition pour lutter contre les taches et/ou le vieillissement de la peau, ses utilisations
FR2737971B1 (fr) * 1995-08-25 1997-11-14 Lvmh Rech Utilisation de la vitamine c ou de ses derives ou analogues pour stimuler la synthese de l'elastine cutanee
US6127409A (en) * 1997-04-30 2000-10-03 Showa Denko Kabushiki Kaisha Ascorbic acid derivative and vitamin C preparation containing the same
JPH10298174A (ja) * 1997-04-30 1998-11-10 Showa Denko Kk アスコルビン酸誘導体及びそれを含有するビタミンc剤
DE19750528A1 (de) * 1997-11-14 1999-05-20 Basf Ag Ascorbylsorbate
DE19750526A1 (de) * 1997-11-14 1999-05-20 Basf Ag Ascorbinsäurederivate enthaltende kosmetische und pharmazeutische Zubereitungen
US6019990A (en) * 1997-11-21 2000-02-01 Natural Nutrition Ltd. As Conjugated linoleic acid delivery system in cosmetic preparations
JP4981198B2 (ja) * 1998-03-31 2012-07-18 格 山本 グリコシル−l−アスコルビン酸のアシル化誘導体
WO1999059580A1 (fr) * 1998-05-15 1999-11-25 Showa Denko K.K. Agents preventifs/therapeutiques pour les affections cutanees
FR2807322B1 (fr) * 2000-04-10 2004-02-20 Oreal Composition, notamment cosmetique, comprenant de l'acide ascorbique en association avec un derive d'acide ascorbique

Also Published As

Publication number Publication date
JP2001316261A (ja) 2001-11-13
EP1145710A1 (de) 2001-10-17
ATE344016T1 (de) 2006-11-15
JP2006070048A (ja) 2006-03-16
EP1145710B1 (de) 2006-11-02
DE60124170T2 (de) 2007-08-30
FR2807320A1 (fr) 2001-10-12
US20020042380A1 (en) 2002-04-11
FR2807320B1 (fr) 2002-05-24
US20030176366A1 (en) 2003-09-18
ES2273789T3 (es) 2007-05-16

Similar Documents

Publication Publication Date Title
ATE344016T1 (de) Verwendung von ascorbinsäurederivaten, um die synthese von epidermalen ceramiden zu erhöhen
ATE434603T1 (de) Chinazolinderivate als antivirale mittel
HRP20041042A2 (en) Novel substituted sulfamate anticonvulsant derivatives
ATE50774T1 (de) Neue fructosyltsansferase und verfahren zur herstellung von fructosyl-disacchariden, sowie eine neue halosaccharose.
KR870001173A (ko) 치환된 피리미딘의 제조방법
DK633088A (da) Kollagenaseinhibitorer
DE60002081D1 (de) Ein komplex enthaltend lignan, phenolische und aliphatische stoffe isoliert von flax und verfahren zur herstellung
PT76470B (fr) Procede de preparation de polymethylene-imines dissubstituees
FI841161A0 (fi) Foerening och komposition foer terapeutisk eller diagnostisk anvaendning jaemte foerfarande foer terapeutis terapeutisk behandling.
EP0193770A3 (de) Neue Derivate von 3,4,5-Trihydroxypiperidin, Verfahren zu ihrer Herstellung und ihre Verwendung
AU2707488A (en) Thiol ketone (or aldehyde) derivatives and pharmaceutical preparations containing them
PT76575B (fr) Procede de preparation de polymethylene-diamines n,n'-substituees
DE3761560D1 (de) Substituierte derivate von n-aethyl(meth)acrylamid, und verfahren zu ihrer herstellung.
BR0107823A (pt) Processo para a obtenção de ácido fórmico anidro ou substancialmente anidro, uso de uma carboxamida, e, aparelho para realizar um processo
HUP0302408A2 (hu) Új aminotriazolon-vegyületek, eljárás ezek előállítására és ezeket tartalmazó gyógyászati készítmények
DE3878074D1 (de) Substituierte pyridylethanolamine, verfahren zu ihrer herstellung und ihre verwendung als leistungsfoerderer bei tieren.
EP0371495A3 (de) Aktive Sialsäureester-Derivate
DE59902329D1 (de) Verfahren zur Herstellung von substituierten Chromanderivaten
BR9714007A (pt) Novos derivados da eritromicina seu processo de preparação e sua aplicação como medicamentos
KR870004038A (ko) 제초제 화합물의 제조방법
BRPI0700539A (pt) composição cosmética, processo para a modelagem ou a manutenção do penteado e uso da composição cosmética
DE59507361D1 (de) Cyclohexan-Derivate, Verfahren zu ihrer Herstellung und die Verwendung als Glukose-6-Phosphatase Inhibitoren
GB868030A (en) Substituted 4-(5-nitrofuryl)-2-oxo-1:2:3:4-tetrahydropyrimidines
FR2873922B1 (fr) Tetrahydropyran(on)es substitues en beta, leur procede de synthese et leur utilisation en parfumerie
HUP0301141A2 (hu) Eljárás trisz-oximszármazékok előállítására

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee